Bruce J. Spohler
Analyst · Ron Jewsikow, Wells Fargo Securities
Thank you, Rich. Let me begin by providing a portfolio update. Overall, the financial performance of our portfolio companies remained steady to improving. While the portfolio is broadly diversified across a variety of industries, we continue to favor issuers operating in more defensive, noncyclical industries. At September 30, our performance -- our portfolio is performing well, and we feel confident about the prospects of our company's operating results going forward. At Q3, the weighted average yield on our portfolio was 7.2% based on fair value versus 7.4% at Q2. Our internal risk assessments on a weighted average value of our portfolio remains at approximately 2 based on our 1:4 risk rating scale with 1 representing the least amount of risk. SUNS ended the second quarter with investment in 39 issuers across 21 industry groups. Our average issuer exposure is approximately $7 million. The portfolio is invested in: 86% senior secured loans; 12% in Gemino senior secured healthcare, whose portfolio is comprised 100% of senior secured loans; 1.5% in unsecured loans; and 0.3% in common equity, excluding our investment in Gemino's loan portfolio and measured at fair value. Including our investment in Gemino at 100% floating rate, over 93% of our income-producing portfolio is floating rate and just under 7% is fixed rate when measured in fair value. During Q3, SUNS made investments of approximately $46 million across 9 portfolio companies and had sales and repayments of approximately $32 million. Before I give an overview of our Q3 investment activity, let me provide a brief update on our investment in Gemino. At quarter-end, Gemino had $112 million of funded senior secured revolving or term loans across 37 different issuers with an average loan balance of approximately $3 million. All of the commitments at Gemino are floating rate senior secured cash paid loans. During the third quarter, Gemino originated new funded loans of approximately $15 million and had excess of just over $5 million. For Q3, Gemino paid distributions to SUNS of $820,000, which equates to a 10% annualized distribution yield on the cost of our investment. This is consistent with the annualized distribution yield for Q2. In addition, Gemino had $83 million outstanding under its $110 million credit facility at quarter-end. Now let me highlight a couple of our Q3 investments. We funded a $10 million first lien investment to help finance Silver Lake's leveraged buyout of Quorum Business Solutions, which is a leading ERP software provider for the oil and gas industry. Total leverage on the company is 4.5x, and our all-in yield is approximately 6%. In addition, we made a $7.5 million investment in the first lien loan for Innovative XCessories & Services, which was acquired by Olympus Partners during Q3. Leverage through our tranche is approximately 4x. We also funded a $5 million investment in the first lien term loan of SkinnyPop Popcorn to support TA Associates' buyout of this company. SkinnyPop is a leading brand in the ready-to eat, better-for-you popcorn segment. Leverage to our first lien tranche is 3.3x, and the yield on our first lien loan is approximately 5.8%. Additionally, we made a $4 million investment in the first lien term loan of tradeMONSTER, which is a leading independent online broker in the retail options trading market, which was acquired by General Atlantic during Q3. The pro forma leverage is 2.6x, and our all-in yield on the investment is 7%. Now let me highlight a couple of our repayments during the third quarter. We were repaid on our $8.5 million investment in the first lien term loan of Jacobs Companies in conjunction with the sale of the business. The IRR on our investment since -- made in July of 2013 was approximately 8.7%. Additionally, our $4 million investment in Marshall Retail was redeemed as part of the sale of that company. As a reminder, Solar Senior invested in Marshall Retail back in October 2011. Our IRR in this investment was just over 8.25%. We were also repaid a par on our $7.25 million investment in the first lien term loan of INSIGHT Pharmaceuticals in connection with the sale of that business. And finally, we exited our remaining $3.5 million investment in the first lien term loan of Catapult Learning, which resulted in IRR of approximately 9%. Based on our fourth quarter activity to date and current visibility for the remainder of the quarter, we are expecting additional portfolio growth in Q4. Now I'll turn the call back to Michael.